Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2872884 | The Annals of Thoracic Surgery | 2014 | 5 Pages |
Abstract
Redo tricuspid valve repair for residual FTR can be performed with acceptable short-term and long-term mortality. However, treatment of FTR at the time of the initial intervention should be considered, because it is safe and effective. A randomized, controlled trial of prophylactic tricuspid operation for FTR at the time of the mitral operation may be warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Nicholas R. MD, Lynn C. MD, Marguerite RN, Francis D. MD, PhD, Jonathan W. MD, Steven F. MD,